Kahn R - Search Results

1

Impact of stochastically generated heterogeneity in hazard rates on individually randomized vaccine efficacy trials.

Kahn R, Hitchings M, Bellan S, Lipsitch M. Kahn R, et al. Clin Trials. 2018 Apr;15(2):207-211. doi: 10.1177/1740774517752671. Epub 2018 Jan 27. Clin Trials. 2018. PMID: 29374974 Free PMC article.

2

Choices in vaccine trial design in epidemics of emerging infections.

Kahn R, Rid A, Smith PG, Eyal N, Lipsitch M. Kahn R, et al. PLoS Med. 2018 Aug 7;15(8):e1002632. doi: 10.1371/journal.pmed.1002632. eCollection 2018 Aug. PLoS Med. 2018. PMID: 30086139 Free PMC article.

3

Analyzing Vaccine Trials in Epidemics With Mild and Asymptomatic Infection.

Kahn R, Hitchings M, Wang R, Bellan SE, Lipsitch M. Kahn R, et al. Am J Epidemiol. 2019 Feb 1;188(2):467-474. doi: 10.1093/aje/kwy239. Am J Epidemiol. 2019. PMID: 30329134 Free PMC article.

4

Incubation periods impact the spatial predictability of cholera and Ebola outbreaks in Sierra Leone.

Kahn R, Peak CM, Fernández-Gracia J, Hill A, Jambai A, Ganda L, Castro MC, Buckee CO. Kahn R, et al. Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):5067-5073. doi: 10.1073/pnas.1913052117. Epub 2020 Feb 13. Proc Natl Acad Sci U S A. 2020. PMID: 32054785 Free PMC article.

5

Individual quarantine versus active monitoring of contacts for the mitigation of COVID-19: a modelling study.

Peak CM, Kahn R, Grad YH, Childs LM, Li R, Lipsitch M, Buckee CO. Peak CM, et al. Among authors: kahn r. Lancet Infect Dis. 2020 Sep;20(9):1025-1033. doi: 10.1016/S1473-3099(20)30361-3. Epub 2020 May 20. Lancet Infect Dis. 2020. PMID: 32445710 Free PMC article.

6

Comparative Impact of Individual Quarantine vs. Active Monitoring of Contacts for the Mitigation of COVID-19: a modelling study.

Peak CM, Kahn R, Grad YH, Childs LM, Li R, Lipsitch M, Buckee CO. Peak CM, et al. Among authors: kahn r. medRxiv. 2020 Mar 8:2020.03.05.20031088. doi: 10.1101/2020.03.05.20031088. Preprint. medRxiv. 2020. PMID: 32511440 Free PMC article. Updated.

7

Potential biases arising from epidemic dynamics in observational seroprotection studies.

Kahn R, Kennedy-Shaffer L, Grad YH, Robins JM, Lipsitch M. Kahn R, et al. medRxiv. 2020 May 6:2020.05.02.20088765. doi: 10.1101/2020.05.02.20088765. Preprint. medRxiv. 2020. PMID: 32511485 Free PMC article. Updated.

8

Nowcasting for Real-Time COVID-19 Tracking in New York City: An Evaluation Using Reportable Disease Data From Early in the Pandemic.

Greene SK, McGough SF, Culp GM, Graf LE, Lipsitch M, Menzies NA, Kahn R. Greene SK, et al. Among authors: kahn r. JMIR Public Health Surveill. 2021 Jan 15;7(1):e25538. doi: 10.2196/25538. JMIR Public Health Surveill. 2021. PMID: 33406053 Free PMC article.

9

Leveraging Pathogen Sequence and Contact Tracing Data to Enhance Vaccine Trials in Emerging Epidemics.

Kahn R, Wang R, Leavitt SV, Hanage WP, Lipsitch M. Kahn R, et al. Epidemiology. 2021 Sep 1;32(5):698-704. doi: 10.1097/EDE.0000000000001367. Epidemiology. 2021. PMID: 34039898

10

Interpreting vaccine efficacy trial results for infection and transmission.

Lipsitch M, Kahn R. Lipsitch M, et al. Among authors: kahn r. Vaccine. 2021 Jul 5;39(30):4082-4088. doi: 10.1016/j.vaccine.2021.06.011. Epub 2021 Jun 12. Vaccine. 2021. PMID: 34130883 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results